The roles of Galectin-3 in autoimmunity and tumor progression

Immunologic Research

Volumn 52, Issue 1-2, 2012, Pages 100-110

  Radosavljevic, Gordana ^a   Volarevic, Vladislav ^a   Jovanovic, Ivan ^a   Milovanovic, Marija ^a   Pejnovic, Nada ^a   Arsenijevic, Nebojsa ^a   Hsu, Daniel K ^b   Lukic, Miodrag L ^a  

^a UNIVERSITY OF KRAGUJEVAC   (Serbia)

^b UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

Con A induced hepatitis; Experimental autoimmune encephalomyelitis; Galectin 3; Melanoma metastasis; Multiple low dose streptozotocin induced diabetes

Indexed keywords

CONCANAVALIN A; GALECTIN 3; GAMMA INTERFERON; INDUCIBLE NITRIC OXIDE SYNTHASE; INTERLEUKIN 10; INTERLEUKIN 17; TUMOR NECROSIS FACTOR ALPHA;

ALLERGIC ENCEPHALOMYELITIS; ANTINEOPLASTIC ACTIVITY; APOPTOSIS; AUTOIMMUNITY; CELL ADHESION; CYTOKINE PRODUCTION; CYTOKINE RELEASE; DENDRITIC CELL; DIABETOGENESIS; DISEASE EXACERBATION; EFFECTOR CELL; GENE EXPRESSION; HEPATITIS; HUMAN; IMMUNE RESPONSE; INFLAMMATION; INNATE IMMUNITY; LIVER INJURY; MACROPHAGE; MELANOMA; METASTASIS; MONONUCLEAR CELL; NATURAL KILLER CELL; NONHUMAN; PANCREAS ISLET BETA CELL; PRIORITY JOURNAL; PROTEIN FUNCTION; REVIEW; STREPTOZOCIN DIABETES; T LYMPHOCYTE ACTIVATION; TUMOR CELL; TUMOR GROWTH;

ANIMALS; APOPTOSIS; AUTOIMMUNITY; CYTOKINES; DENDRITIC CELLS; DIABETES MELLITUS, EXPERIMENTAL; ENCEPHALOMYELITIS, AUTOIMMUNE, EXPERIMENTAL; GALECTIN 3; HEPATITIS; HUMANS; LYMPHOCYTE ACTIVATION; MACROPHAGES; MELANOMA; MICE; NEOPLASMS; T-LYMPHOCYTES;

EID: 84859893633     PISSN: 0257277X     EISSN: 15590755     Source Type: Journal    
DOI: 10.1007/s12026-012-8286-6     Document Type: Review

References (113)

1. S Sato C St-Pierre P Bhaumik J Nieminen 2009 Galectins in innate immunity: dual functions of host soluble beta-galactoside-binding lectins as damage-associated molecular patterns (DAMPs) and as receptors for pathogen-associated molecular patterns (PAMPs) Immunol Rev 230 172 187 19594636 1:CAS:528:DC%2BD1MXhsFGls7fI 10.1111/j.1600-065X.2009.00790.x
2. NC Henderson T Sethi 2009 The regulation of inflammation by galectin-3 Immunol Rev 230 1 160 171 19594635 1:CAS:528:DC%2BD1MXhsFGls7fP 10.1111/j.1600-065X.2009.00794.x
3. H Leffler S Carlsson M Hedlund Y Qian F Poirier 2004 Introduction to galectins Glycoconj J 19 7-9 433 440 14758066
4. DN Cooper SH Barondes 1999 God must love galectins; he made so many of them Glycobiology 9 979 984 10521533 1:CAS:528:DyaK1MXmsVCjsbo%3D 10.1093/glycob/9.10.979
5. RY Yang GA Rabinovich FT Liu 2008 Galectins: structure, function and therapeutic potential Expert Rev Mol Med 10 e17 18549522 10.1017/ S1462399408000719
6. GA Rabinovich LG Baum N Tinari R Paganelli C Natoli FT Liu S Iacobelli 2002 Galectins and their ligands: amplifiers, silencers or tuners of the inflammatory response? Trends Immunol 23 6 313 320 12072371 1:CAS:528: DC%2BD38XksF2hu7c%3D 10.1016/S1471-4906(02)02232-9
7. MK Ho TA Springer 1982 Mac-2, a novel 32,000 Mr mouse macrophage subpopulation-specific antigen defined by monoclonal antibodies J Immunol 128 1221 1228 6173426 1:CAS:528:DyaL38Xht1SmtLs%3D
8. J Herrmann CW Turck RE Atchison ME Huflejt L Poulter MA Gitt AL Burlingame SH Barondes H Leffler 1993 Primary structure of the soluble lactose binding lectin L-29 from rat and dog and interaction of its non-collagenous proline-, glycine-, tyrosine-rich sequence with bacteria and tissue collagenase J Biol Chem 268 26704 26711 8253805 1:CAS:528:DyaK3sXmsVCiur4%3D
9. SH Barondes DN Cooper MA Gitt H Leffler 1994 Galectins: structure and function of a large family of animal lectins J Biol Chem 269 33 20807 20810 8063692 1:CAS:528:DyaK2cXlsFWgurc%3D
10. HC Gong Y Honjo P Nangia-Makker V Hogan N Mazurak RS Bresalier A Raz 1999 The NH2 terminus of galectin-3 governs cellular compartmentalization and functions in cancer cells Cancer Res 59 24 6239 6245 10626818 1:CAS:528:DC%2BD3cXktFyguw%3D%3D
11. J Ochieng B Green S Evans O James P Warfield 1998 Modulation of the biological functions of galectin-3 by matrix metalloproteinases Biochim Biophys Acta 1379 1 97 106 9468337 1:CAS:528:DyaK1cXhsFakug%3D%3D 10.1016/S0304-4165(97) 00086-X
12. RY Yang DK Hsu FT Liu 1996 Expression of galectin-3 modulates T-cell growth and apoptosis Proc Natl Acad Sci USA 93 6737 6742 8692888 1:CAS:528:DyaK28XjvFeisbk%3D 10.1073/pnas.93.13.6737
13. S Sato RCJ Hughes 1994 Regulation of secretion and surface expression of Mac-2, a galactoside-binding protein of macrophages J Biol Chem 269 4424 4430 8308013 1:CAS:528:DyaK2cXhs1WgtLk%3D
14. IK Moutsatsos M Wade M Schindler JL Wang 1987 Endogenous lectins from cultured cells: nuclear localization of carbohydrate-binding protein 35 in proliferating 3T3 fibroblasts Proc Natl Acad Sci USA 84 6452 6456 3306680 1:CAS:528:DyaL2sXlslegurs%3D 10.1073/pnas.84.18.6452
15. NL Perillo ME Marcus LG Baum 1998 Galectins: versatile modulators of cell adhesion, cell proliferation, and cell death J Mol Med 76 402 412 9625297 1:CAS:528:DyaK1cXjsleku7k%3D 10.1007/s001090050232
16. N Ahmad HJ Gabius S André H Kaltner S Sabesan R Roy B Liu F Macaluso CF Brewer 2004 Galectin-3 precipitates as a pentamer with synthetic multivalent carbohydrates and forms heterogeneous cross-linked complexes J Biol Chem 279 12 10841 10847 14672941 1:CAS:528:DC%2BD2cXitFyit7k%3D 10.1074/jbc.M312834200
17. FT Liu GA Rabinovich 2005 Galectins as modulators of tumour progression Nat Rev Cancer 5 29 41 15630413 1:CAS:528:DC%2BD2MXlvVem 10.1038/nrc1527
18. J Dumic S Dabelic M Flögel 2006 Galectin-3: an open-ended story Biochim Biophys Acta 1760 616 635 16478649 1:CAS:528:DC%2BD28Xjsl2mtrw%3D 10.1016/j.bbagen.2005.12.020
19. SF Dagher JL Wang RJ Patterson 1995 Identification of galectin-3 as a factor in pre-mRNA splicing Proc Natl Acad Sci USA 92 4 1213 1217 7862663 1:CAS:528:DyaK2MXjslegsbg%3D 10.1073/pnas.92.4.1213
20. JL Wang RM Gray KC Haudek RJ Patterson 2004 Nucleocytoplasmic lectins Biochim Biophys Acta 1673 1-2 75 93 15238251 1:CAS:528:DC%2BD2cXltl2htbo%3D 10.1016/j.bbagen.2004.03.013
21. S Califice V Castronovo M Bracke F van den Brûle 2004 Dual activities of galectin-3 in human prostate cancer: tumor suppression of nuclear galectin-3 vs tumor promotion of cytoplasmic galectin-3 Oncogene 23 45 7527 7536 15326483 1:CAS:528:DC%2BD2cXnvFGkur4%3D 10.1038/sj.onc.1207997
22. S Nakahara N Oka A Raz 2005 On the role of galectin-3 in cancer apoptosis Apoptosis 10 2 267 275 15843888 1:CAS:528:DC%2BD2MXjtl2ktL4%3D 10.1007/s10495-005-0801-y
23. BN Stillman DK Hsu M Pang CF Brewer P Johnson FT Liu LG Baum 2006 Galectin-3 and galectin-1 bind distinct cell surface glycoprotein receptors to induce T cell death J Immunol 176 778 789 16393961 1:CAS:528: DC%2BD28Xht1Cqtg%3D%3D
24. T Fukumori Y Takenaka T Yoshii HRC Kim V Hogan H Inohara S Kagawa A Raz 2003 CD29 and CD7 mediate galectin-3-induced type II T-cell apoptosis Cancer Res 63 8302 8311 14678989 1:CAS:528:DC%2BD3sXpvVagtL4%3D
25. M Demetriou M Granovsky S Quaggin JW Dennis 2001 Negative regulation of T-cell activation and autoimmunity by Mgat5 N-glycosylation Nature 409 733 739 11217864 1:CAS:528:DC%2BD3MXht1ymsLk%3D 10.1038/35055582
26. Liu FT, Hsu D K, Zuberi RI, Kuwabara I, Chi EY, Henderson WR Jr. Expression and function of galectin-3, a b-galactoside-binding lectin, in human monocytes and macrophages. Am J Pathol. 1995;147:1016-29.
27. H Sano DK Hsu L Yu JR Apgar I Kuwabara T Yamanaka M Hirashima FT Liu 2000 Human galectin-3 is a novel chemoattractant for monocytes and macrophages J Immunol 165 2156 2164 10925302 1:CAS:528:DC%2BD3cXls1Kmtr0%3D
28. I Kuwabara FT Liu 1996 Galectin-3 promotes adhesion of human neutrophils to laminin J Immunol 156 3939 3944 8621934 1:CAS:528:DyaK28XivVamsLc%3D
29. S Sato N Ouellet I Pelletier M Simard A Rancourt MG Bergeron 2002 Role of galectin-3 as an adhesion molecule for neutrophil extravasation during streptococcal pneumonia J Immunol 168 1813 1822 11823514 1:CAS:528: DC%2BD38Xht1Cns7s%3D
30. K Christenson M Matlak Å Björstad KL Brown E Telemo E Salomonsson H Leffler J Bylund 2009 Galectin-3 functions as an opsonin and enhances the macrophage clearance of apoptotic neutrophils Glycobiology 19 16 20 18849325
31. X Xiao P Zhao D Rodriguez-Pinto D Qi O Henegariu L Alexopoulou A Flavell S Wong L Wen 2009 Inflammatory regulation by TLR3 in acute hepatitis J Immunol 183 3712 3719 19710451 1:CAS:528:DC%2BD1MXhtVOmurnO 10.4049/jimmunol.0901221
32. A Itoh K Isoda M Kondoh M Kawase M Kobayashi M Tamesada K Yagi 2009 Hepatoprotective effect of syringic acid and vanillic acid on concanavalin a-induced liver injury Biol Pharm Bull 32 1215 1219 19571388 1:CAS:528:DC%2BD1MXhtVGhur7M 10.1248/bpb.32.1215
33. AM Wolf D Wolf MA Avila AR Moschen C Berasain B Enrich H Rumpold H Tilg 2006 Up-regulation of the anti-inflammatory adipokine adiponectin in acute liver failure in mice J Hepatol 44 537 543 16310276 1:CAS:528:DC%2BD28XhsFKktr8%3D 10.1016/j.jhep.2005.08.019
34. JC Hanson MK Bostick CB Campe P Kodali G Lee J Yan JJ Maher 2006 Transgenic overexpression of interleukin-8 in mouse liver protects against galactosamine/endotoxin toxicity J Hepatol 44 359 367 16168518 1:CAS:528:DC%2BD28XksVSjsw%3D%3D 10.1016/j.jhep.2005.06.022
35. G Tiegs J Hentschel A Wendel 1992 A T cell-dependent experimental liver injury in mice inducible by concanavalin A J Clin Invest 90 196 203 1634608 1:CAS:528:DyaK38XltVGqtrw%3D 10.1172/JCI115836
36. F Gantner M Leist W Lohse G Germann G Tiegs 1995 Concanavalin A-induced T-cell-mediated hepatic injury in mice: the role of tumor necrosis factor Hepatology 21 190 198 7806154 1:CAS:528:DyaK2MXjs1ygsLY%3D
37. V Volarevic M Mitrovic M Milovanovic I Zelen I Nikolic S Mitrovic N Pejnovic N Arsenijevic M Lukic 2012 Protective role of IL-33/ST2 axis in con A-induced hepatitis J Hepatol 56 1 26 33 21703183 1:CAS:528:DC%2BC3MXhs1GhsbnN 10.1016/j.jhep.2011.03.022
38. J Wang R Sun H Wei Z Dong B Gao TianZ Poly 2006 Poly I: C prevents T cell-mediated hepatitis via an NK-dependent mechanism J Hepatol 44 446 454 16310275 1:CAS:528:DC%2BD28XhsFKksbo%3D 10.1016/j.jhep.2005.08.015
39. K Takeda Y Hayakawa L Van Kaer H Matsuda H Yagita K Okumura 2000 Critical contribution of liver natural killer T cells to a murine model of hepatitis Proc Natl Acad Sci USA 97 5498 5503 10792025 1:CAS:528:DC%2BD3cXjsVWms78%3D 10.1073/pnas.040566697
40. Y Matsuda Y Yamagiwa K Fukushima Y Ueno T Shimosegawa 2008 Expression of galectin-3 involved in prognosis of patients with hepatocellular carcinoma Hepatol Res 38 1098 1111 18684128 1:CAS:528:DC%2BD1cXhsVWju7zK 10.1111/j.1872-034X.2008.00387.x
41. S Wongkham M Junking C Wongkham B Sripa S Chur-In N Araki 2009 Suppression of galectin-3 expression enhances apoptosis and chemosensitivity in liver fluke-associated cholangiocarcinoma Cancer Sci 100 2077 2084 19723119 1:CAS:528:DC%2BD1MXhsVSktLbJ 10.1111/j.1349-7006.2009.01304.x
42. NC Henderson AC Mackinnon SL Farnworth F Poirier FP Russo JP Iredale C Haslett KJ Simpson T Sethi 2006 Galectin-3 regulates myofibroblast activation and hepatic fibrosis Proc Natl Acad Sci U S A 103 5060 5065 16549783 1:CAS:528:DC%2BD28XjsVGlsbs%3D 10.1073/pnas.0511167103
43. C Iacobini S Menini C Ricci C Blasetti Fantauzzi A Scipioni L Salvi S Cordone F Delucchi M Serino M Federici F Pricci G Pugliese 2011 Galectin-3 ablation protects mice from diet-induced NASH: a major scavenging role for galectin-3 in liver J Hepatol 54 5 975 983 21145823 1:CAS:528: DC%2BC3MXkvFGhu7c%3D 10.1016/j.jhep.2010.09.020
44. HG Joo PS Goedegebuure N Sadanaga M Nagoshi W von Bernstorff TJ Eberlein 2001 Expression and function of galectin-3, a beta-galactoside-binding protein in activated T lymphocytes J Leukoc Biol 69 555 564 11310841 1:CAS:528:DC%2BD3MXivVagurc%3D
45. SB Jeon HJ Yoon CY Chang HS Koh SH Jeon EJ Park 2010 Galectin-3 exerts cytokine-like regulatory actions through the JAK-STAT pathway J Immunol 185 7037 7046 20980634 1:CAS:528:DC%2BC3cXhsVaqtL%2FP 10.4049/jimmunol.1000154
46. L Breuilh F Vanhoutte J Fontaine CM van Stijn I Tillie-Leblond M Capron C Faveeuw T Jouault I van Die P Gosset F Trottein 2007 Galectin-3 modulates immune and inflammatory responses during helminthic infection: impact of galectin-3 deficiency on the functions of dendritic cells Infect Immun 75 5148 5157 17785480 1:CAS:528:DC%2BD2sXht1CrtLzE 10.1128/IAI.02006-06
47. Cumpstey I, Sundin A, Leffler H, Nilsson UJ. C2-symmetrical thiodigalactoside bis-benzamido derivatives as high-affinity inhibitors of galectin-3: efficient lectin inhibition through double arginine-arene interactions. Angew Chem Int Ed Engl. 2005;44(32):5110-12.
48. Sato S, Nieminen J. Seeing strangers or announcing "danger": galectin-3 in two models of innate immunity. Glycoconj J. 2004;19(7-9):583-91.
49. JP Cerliani SR Stowell ID Mascanfroni CM Arthur RD Cummings GA Rabinovich 2011 Expanding the universe of cytokines and pattern recognition receptors: galectins and glycans in innate immunity J Clin Immunol 31 1 10 21 21184154 1:CAS:528:DC%2BC3MXjvVemtbk%3D 10.1007/s10875-010-9494-2
50. TK van den Berg H Honing N Franke A van Remoortere WE Schiphorst FT Liu AM Deelder RD Cummings CH Hokke I van Die 2004 LacdiNAc-glycans constitute a parasite pattern for galectin-3-mediated immune recognition J Immunol 173 3 1902 1907 15265923
51. CM John GA Jarvis KV Swanson H Leffler MD Cooper ME Huflejt JM Griffiss 2002 Galectin-3 binds lactosaminylated lipooligosaccharides from Neisseria gonorrhoeae and is selectively expressed by mucosal epithelial cells that are infected Cell Microbiol 4 649 662 12366402 1:CAS:528:DC%2BD38XotFGlt70%3D 10.1046/j.1462-5822.2002.00219.x
52. I Pelletier S Sato 2002 Specific recognition and cleavage of galectin-3 by Leishmania major through species-specific polygalactose epitope J Biol Chem 277 20 17663 17670 11882664 1:CAS:528:DC%2BD38XktVCnsr4%3D 10.1074/jbc. M201562200
53. Silva-Monteiro E, Reis Lorenzato L, Kenji Nihei O, Junqueira M, Rabinovich GA, Hsu DK, Liu FT, Savino W, Chammas R, Villa-Verde DM. Altered expression of galectin-3 induces cortical thymocyte depletion and premature exit of immature thymocytes during Trypanozoma cruzi infection. Am J Pathol. 2007;170(2):546-56.
54. ES Bernardes NM Silva LP Ruas JR Mineo AM Loyola DK Hsu FT Liu R Chammas MC Roque-Barreira 2006 Toxoplasma gondii infection reveals a novel regulatory role for galectin-3 in the interface of innate and adaptive immunity Am J Pathol 168 6 1910 1920 16723706 1:CAS:528:DC%2BD28XlvVOhsLs%3D 10.2353/ajpath.2006. 050636
55. LP Ruas ES Bernardes ML Fermino LL de Oliveira DK Hsu FT Liu R Chammas MC Roque-Barreira 2009 Lack of galectin-3 drives response to Paracoccidioides brasiliensis toward a Th2-biased immunity PLoS One 4 2 e4519 19229338 10.1371/journal.pone.0004519 1:CAS:528:DC%2BD1MXis1Knurg%3D
56. HR Jiang Z Al Rasebi E Mensah-Brown A Shahin D Xu CS Goodyear SY Fukada FT Liu FY Liew ML Lukic 2009 Galectin-3 deficiency reduces the severity of experimental autoimmune encephalomyelitis J Immunol 182 2 1167 1173 19124760 1:CAS:528:DC%2BD1MXhsVKrsg%3D%3D
57. EP Mensah-Brown A Shahin M Al-Shamisi X Wei ML Lukic 2006 IL-23 leads to diabetes induction after subdiabetogenic treatment with multiple low doses of streptozotocin Eur J Immunol 36 1 216 223 16358360 1:CAS:528: DC%2BD28XntVSmsA%3D%3D 10.1002/eji.200535325
58. EP Mensah-Brown Z Al Rabesi A Shahin M Al Shamsi N Arsenijevic DK Hsu FT Liu ML Lukic 2009 Targeted disruption of the galectin-3 gene results in decreased susceptibility to multiple low dose streptozotocin-induced diabetes in mice Clin Immunol 130 83 88 18845486 1:CAS:528:DC%2BD1cXhsV2gt77J 10.1016/j.clim.2008.08.024
59. H Sano DK Hsu JR Apgar L Yu BB Sharma I Kuwabara S Izui FT Liu 2003 Critical role of galectin-3 in phagocytosis by macrophages J Clin Invest 112 3 389 397 12897206 1:CAS:528:DC%2BD3sXmtFemtrw%3D
60. M Cnop N Welsh JC Jonas A Jörns S Lenzen DL Eizirik 2005 Mechanisms of pancreatic beta-cell death in type 1 and type 2 diabetes: many differences, few similarities Diabetes 54 Suppl 2 S97 S107 16306347 1:CAS:528: DC%2BD2MXht12gs7nF 10.2337/diabetes.54.suppl-2.S97
61. Masters SL, Dunne A, Subramanian SL, Hull RL, Tannahill GM, Sharp FA, Becker C, Franchi L, Yoshihara E, Chen Z, Mullooly N, Mielke LA, Harris J, Coll RC, Mills KH, Mok KH, Newsholme P, Nuñez G, Yodoi J, Kahn SE, Lavelle EC, O'Neill LA. Activation of the NLRP3 inflammasome by islet amyloid polypeptide provides a mechanism for enhanced IL-1beta in type 2 diabetes. Nat Immunol. 2010;11(10):897-04.
62. SW Mok KM Thelen C Riemer T Bamme S Gültner D Lütjohann M Baier 2006 Simvastatin prolongs survival times in prion infections of the central nervous system Biochem Biophys Res Commun 348 2 697 702 16890918 1:CAS:528:DC%2BD28Xot1aitbY%3D 10.1016/j.bbrc.2006.07.123
63. SW Mok C Riemer K Madela DK Hsu FT Liu S Gültner I Heise M Baier 2007 Role of galectin-3 in prion infections of the CNS Biochem Biophys Res Commun 359 3 672 678 17555713 1:CAS:528:DC%2BD2sXmsFykt7c%3D 10.1016/j.bbrc.2007.05.163
64. CL Bellac RS Coimbra F Simon H Imboden SL Leib 2007 Gene and protein expression of galectin-3 and galectin-9 in experimental pneumococcal meningitis Neurobiol Dis 28 2 175 183 17706429 1:CAS:528:DC%2BD2sXht1aktr%2FM 10.1016/j.nbd.2007.07.005
65. HL Weiner 2008 A shift from adaptive to innate immunity: a potential mechanism of disease progression in multiple sclerosis J Neurol 255 Suppl 1 3 11 18317671 1:CAS:528:DC%2BD1cXovV2rtbY%3D 10.1007/s00415-008-1002-8
66. RS Liblau SM Singer HO McDevitt 1995 Th1 and Th2 CD4+ T cells in the pathogenesis of organ-specific autoimmune diseases Immunol Today 16 1 34 38 7880387 1:CAS:528:DyaK2MXjsVyjtrY%3D 10.1016/0167-5699(95)80068-9
67. L Steinman 2008 A rush to judgment on Th17 J Exp Med 205 7 1517 1522 18591407 1:CAS:528:DC%2BD1cXosVKktrg%3D 10.1084/jem.20072066
68. H Park Z Li XO Yang SH Chang R Nurieva YH Wang Y Wang L Hood Z Zhu Q Tian C Dong 2005 A distinct lineage of CD4 T cells regulates tissue inflammation by producing interleukin 17 Nat Immunol 6 11 1133 1141 16200068 1:CAS:528:DC%2BD2MXhtFamsb%2FO 10.1038/ni1261
69. CL Langrish Y Chen WM Blumenschein J Mattson B Basham JD Sedgwick T McClanahan RA Kastelein DJ Cua 2005 IL-23 drives a pathogenic T cell population that induces autoimmune inflammation J Exp Med 201 2 233 240 15657292 1:CAS:528:DC%2BD2MXot12mtA%3D%3D 10.1084/jem.20041257
70. A Grigorian S Torossian M Demetriou 2009 T-cell growth, cell surface organization, and the galectin-glycoprotein lattice Immunol Rev 230 1 232 246 19594640 1:CAS:528:DC%2BD1MXhsFGls7fE 10.1111/j.1600-065X.2009.00796.x
71. C Zhu AC Anderson A Schubart H Xiong J Imitola SJ Khoury XX Zheng TB Strom VK Kuchroo 2005 The Tim-3 ligand galectin-9 negatively regulates T helper type 1 immunity Nat Immunol 6 12 1245 1252 16286920 1:CAS:528:DC%2BD2MXhtlShurrO 10.1038/ni1271
72. S Ohshima S Kuchen CA Seemayer D Kyburz A Hirt S Klinzing BA Michel RE Gay FT Liu S Gay M Neidhart 2003 Galectin 3 and its binding protein in rheumatoid arthritis Arthritis Rheum 48 2788 2795 14558084 1:CAS:528: DC%2BD3sXpt1Srsr4%3D 10.1002/art.11287
73. H Forsman U Islander E Andréasson A Andersson K Onnheim A Karlström K Sävman M Magnusson KL Brown A Karlsson 2011 Galectin 3 aggravates joint inflammation and destruction in antigen-induced arthritis Arthritis Rheum 63 445 454 21280000 1:CAS:528:DC%2BC3MXivVOksro%3D 10.1002/art.30118
74. M Nachtigal Z Al-Assaad EP Mayer K Kim M Monsigny 1988 Galectin-3 expression in human atherosclerotic lesions Am J Pathol 152 1199 11208
75. C Iacobini S Menini C Ricci A Scipioni V Sansoni S Cordone M Taurino M Serino G Marano M Federici F Pricci G Pugliese 2009 Accelerated lipid-induced atherogenesis in galectin-3-deficient mice: role of lipoxidation via receptor-mediated mechanisms Arterioscler Thromb Vasc Biol 29 6 831 836 19359660 1:CAS:528:DC%2BD1MXlslCnsb0%3D 10.1161/ATVBAHA.109.186791
76. Y Honjo P Nangia-Makker H Inohara A Raz 2001 Downregulation of galectin-3 suppresses tumorigenicity of human breast carcinoma cells Clin Cancer Res 7 661 668 11297262 1:CAS:528:DC%2BD3MXjtVOgu7k%3D
77. T Yoshii H Inohara Y Takenaka Y Honjo S Akahani T Nomura A Raz T Kubo 2001 Galectin-3 maintains the transformed phenotype of thyroid papillary carcinoma cells Int J Oncol 18 4 787 792 11251175 1:CAS:528:DC%2BD3MXivVWqtbs%3D
78. G Elad-Sfadia R Haklai E Balan Y Kloog 2004 Galectin-3 augments K-Ras activation and triggers a Ras signal that attenuates ERK but not phosphoinositide 3-kinase activity J Biol Chem 279 33 34922 34930 15205467 1:CAS:528:DC%2BD2cXmvFemsbY%3D 10.1074/jbc.M312697200
79. U Ashery O Yizhar B Rotblat G Elad-Sfadia B Barkan R Haklai Y Kloog 2006 Spatiotemporal organization of Ras signaling: rasosomes and the galectin switch Cell Mol Neurobiol 26 4-6 471 495 16691442 1:CAS:528:DC%2BD28Xhtleksb%2FK
80. T Shimura Y Takenaka T Fukumori S Tsutsumi K Okada V Hogan A Kikuchi H Kuwano A Raz 2005 Implication of galectin-3 in Wnt signaling Cancer Res 65 9 3535 3537 15867344 1:CAS:528:DC%2BD2MXjslGltbg%3D 10.1158/0008-5472.CAN-05-0104
81. HR Kim HM Lin H Biliran A Raz 1999 Cell cycle arrest and inhibition of anoikis by galectin-3 in human breast epithelial cells Cancer Res 59 4148 4154 10463621 1:CAS:528:DyaK1MXlsVOlu7w%3D
82. T Shimura Y Takenaka S Tsutsumi V Hogan A Kikuchi A Raz 2004 Galectin-3, a novel binding partner of beta-catenin Cancer Res 64 18 6363 6367 15374939 1:CAS:528:DC%2BD2cXnsFOlt7o%3D 10.1158/0008-5472.CAN-04-1816
83. H Inohara A Raz 1995 Functional evidence that cell surface galectin-3 mediates homotypic cell adhesion Cancer Res 55 15 3267 3271 7542167 1:CAS:528:DyaK2MXnt1ansL0%3D
84. H Inohara S Akahani K Koths A Raz 1996 Interactions between galectin-3 and Mac-2-binding protein mediate cell-cell adhesion Cancer Res 56 19 4530 4534 8813152 1:CAS:528:DyaK28XmtVyltbk%3D
85. SK Khaldoyanidi VV Glinsky L Sikora AB Glinskii VV Mossine TP Quinn GV Glinsky P Sriramarao 2003 MDA-MB-435 human breast carcinoma cell homo- and heterotypic adhesion under flow conditions is mediated in part by Thomsen-Friedenreich antigen-galectin-3 interactions J Biol Chem 278 4127 4134 12438311 1:CAS:528:DC%2BD3sXot1ygug%3D%3D 10.1074/jbc.M209590200
86. VV Glinsky GV Glinsky K Rittenhouse-Olson ME Huflejt OV Glinskii SL Deutscher TP Quinn 2001 The role of Thomsen-Friedenreich antigen in adhesion of human breast and prostate cancer cells to the endothelium Cancer Res 61 4851 4857 11406562 1:CAS:528:DC%2BD3MXks1Gru74%3D
87. Y Takenaka T Fukumori A Raz 2004 Galectin-3 and metastasis Glycoconj J 19 543 549 14758078 10.1023/B:GLYC.0000014084.01324.15
88. Q Zhao M Barclay J Hilkens X Guo H Barrow JM Rhodes LG Yu 2010 Interaction between circulating galectin-3 and cancer-associated MUC1 enhances tumour cell homotypic aggregation and prevents anoikis Mol Cancer 9 154 20565834 10.1186/1476-4598-9-154 1:CAS:528:DC%2BC3cXot1emtrY%3D
89. G Méhes A Witt E Kubista PF Ambros 2001 Circulating breast cancer cells are frequently apoptotic Am J Pathol 159 17 20 11438448 10.1016/S0002-9440(10)61667-7
90. RS Kerbel H Kobayashi CH Graham 1994 Intrinsic or acquired drug resistance and metastasis: are they linked phenotypes? J Cell Biochem 56 1 37 47 7806590 1:CAS:528:DyaK2cXlvFCkt74%3D 10.1002/jcb.240560108
91. P Matarrese O Fusco N Tinari C Natoli FT Liu ML Semeraro W Malorni S Iacobelli 2000 Galectin-3 overexpression protects from apoptosis by improving cell adhesion properties Int J Cancer 85 4 545 554 10699929 1:CAS:528: DC%2BD3cXht1amt74%3D 10.1002/(SICI)1097-0215(20000215)85:4<545::AID- IJC17>3.0.CO;2-N
92. P Matarrese N Tinari ML Semeraro C Natoli S Iacobelli W Malorni 2000 Galectin-3 overexpression protects from cell damage and death by influencing mitochondrial homeostasis FEBS Lett 473 3 311 315 10818231 1:CAS:528: DC%2BD3cXjt1eju7k%3D 10.1016/S0014-5793(00)01547-7
93. T Fukumori HO Kanayama A Raz 2007 The role of galectin-3 in cancer drug resistance Drug Resist Updat 10 3 101 108 17544840 1:CAS:528: DC%2BD2sXnslWksr8%3D 10.1016/j.drup.2007.04.001
94. O'Driscoll L, Linehan R, Liang YH, Joyce H, Oglesby I, Clynes M. Galectin-3 expression alters adhesion, motility and invasion in a lung cell line (DLKP), in vitro. Anticancer Res. 2002;22(6A):3117-125.
95. JD Hood DA Cheresh 2002 Role of integrins in cell invasion and migration Nat Rev Cancer 2 2 91 100 12635172 10.1038/nrc727
96. SJ Kim JY Shin KD Lee YK Bae IJ Choi SH Park KH Chun 2011 Galectin-3 facilitates cell motility in gastric cancer by up-regulating protease-activated receptor-1 (PAR-1) and matrix metalloproteinase-1 (MMP-1) PLoS One 6 9 e25103 21966428 1:CAS:528:DC%2BC3MXhtlamu7%2FL 10.1371/journal.pone.0025103
97. P Nangia-Makker Y Honjo R Sarvis S Akahani V Hogan KJ Pienta A Raz 2000 Galectin-3 induces endothelial cell morphogenesis and angiogenesis Am J Pathol 156 3 899 909 10702407 1:CAS:528:DC%2BD3cXitVeru7g%3D 10.1016/S0002-9440(10) 64959-0
98. S Califice V Castronovo F Van Den Brûle 2004 Galectin-3 and cancer (review) Int J Oncol 25 4 983 992 15375548 1:CAS:528:DC%2BD2cXovFWks7o%3D
99. C Lurquin B Lethé E De Plaen V Corbière I Théate N van Baren PG Coulie T Boon 2005 Contrasting frequencies of antitumor and anti-vaccine T cells in metastases of a melanoma patient vaccinated with a MAGE tumor antigen J Exp Med 201 2 249 257 15657294 1:CAS:528:DC%2BD2MXot12mug%3D%3D 10.1084/jem.20041378
100. J Carrasco A Van Pel B Neyns B Lethé F Brasseur N Renkvist P van der Bruggen N van Baren R Paulus K Thielemans T Boon D Godelaine 2008 Vaccination of a melanoma patient with mature dendritic cells pulsed with MAGE-3 peptides triggers the activity of nonvaccine anti-tumor cells J Immunol 180 3585 3593 18292586 1:CAS:528:DC%2BD1cXit1OktLg%3D
101. G Carcelain N Rouas-Freiss E Zorn V Chung-Scott S Viel F Faure J Bosq T Hercend 1997 In situ T-cell responses in a primary regressive melanoma and subsequent metastases: a comparative analysis Int J Cancer 72 2 241 247 9219827 1:CAS:528:DyaK2sXkslylsbk%3D 10.1002/(SICI)1097-0215(19970717)72:2<241::AID- IJC7>3.0.CO;2-R
102. TF Gajewski Y Meng C Blank I Brown A Kacha J Kline H Harlin 2006 Immune resistance orchestrated by the tumor microenvironment Immunol Rev 213 131 145 16972901 1:CAS:528:DC%2BD28XhtF2lsrbL 10.1111/j.1600-065X.2006.00442.x
103. F Marincola EM Jaffee DJ Hicklin S Ferrone 2000 Escape of human solid tumors from T-cell recognition: molecular mechanisms and functional significance Adv Immunol 74 181 273 10605607 1:CAS:528:DC%2BD3cXivVehu7c%3D 10.1016/S0065-2776(08)60911-6
104. N Demotte V Stroobant PJ Courtoy P Van Der Smissen D Colau IF Luescher C Hivroz J Nicaise JL Squifflet M Mourad D Godelaine T Boon P van der Bruggen 2008 Restoring the association of the T cell receptor with CD8 reverses anergy in human tumor-infiltrating lymphocytes Immunity 28 3 414 424 18342010 1:CAS:528:DC%2BD1cXjvFeksb8%3D 10.1016/j.immuni.2008.01.011
105. MR Zubieta D Furman M Barrio AI Bravo E Domenichini J Mordoh 2006 Galectin-3 expression correlates with apoptosis of tumor-associated lymphocytes in human melanoma biopsies Am J Pathol 168 5 1666 1675 16651632 1:CAS:528:DC%2BD28XkvF2ntb0%3D 10.2353/ajpath.2006.050971
106. G Radosavljevic I Jovanovic I Majstorovic M Mitrovic VJ Lisnic N Arsenijevic S Jonjic ML Lukic 2011 Deletion of galectin-3 in the host attenuates metastasis of murine melanoma by modulating tumor adhesion and NK cell activity Clin Exp Metastasis 28 5 451 462 21442355 1:CAS:528:DC%2BC3MXltFCitrY%3D 10.1007/s10585-011-9383-y
107. Abdel-Aziz HO, Murai Y, Takasaki I, Tabuchi Y, Zheng HC, Nomoto K, Takahashi H, Tsuneyama K, Kato I, Hsu DK, Liu FT, Hiraga K, Takano Y. Targeted disruption of the galectin-3 gene results in decreased susceptibility to NNK-induced lung tumorigenesis: an oligonucleotide microarray study. J Cancer Res Clin Oncol. 2008;134(7):777-88.
108. I Iurisci N Tinari C Natoli D Angelucci E Cianchetti S Iacobelli 2000 Concentrations of galectin-3 in the sera of normal controls and cancer patients Clin Cancer Res 6 4 1389 1393 10778968 1:CAS:528:DC%2BD3cXjtVOqt7k%3D
109. Vereecken P, Zouaoui Boudjeltia K, Debray C, Awada A, Legssyer I, Sales F, Petein M, Vanhaeverbeek M, Ghanem G, Heenen M. High serum galectin-3 in advanced melanoma: preliminary results. Clin Exp Dermatol. 2006;31(1):105-09.
110. T Dittmar C Heyder E Gloria-Maercker W Hatzmann KS Zänker 2008 Adhesion molecules and chemokines: the navigation system for circulating tumor (stem) cells to metastasize in an organ-specific manner Clin Exp Metastasis 25 1 11 32 17828597 1:CAS:528:DC%2BD1cXkslaltrg%3D 10.1007/s10585-007-9095-5
111. V Krishnan SM Bane PD Kawle KN Naresh RD Kalraiya 2005 Altered melanoma cell surface glycosylation mediates organ specific adhesion and metastasis via lectin receptors on the lung vascular endothelium Clin Exp Metastasis 22 1 11 24 16132574 1:CAS:528:DC%2BD2MXhtFegtrfJ 10.1007/s10585-005-2036-2
112. F Ghiringhelli C Ménard M Terme C Flament J Taieb N Chaput PE Puig S Novault B Escudier E Vivier A Lecesne C Robert JY Blay J Bernard S Caillat-Zucman A Freitas T Tursz O Wagner-Ballon C Capron W Vainchencker F Martin L Zitvogel 2005 CD4+ CD25+ regulatory T cells inhibit natural killer cell functions in a transforming growth factor-beta-dependent manner J Exp Med 202 8 1075 1085 16230475 1:CAS:528:DC%2BD2MXhtFelu7rL 10.1084/jem.20051511
113. MJ Smyth MW Teng J Swann K Kyparissoudis DI Godfrey Y Hayakawa 2006 CD4+ CD25+ T regulatory cells suppress NK cell-mediated immunotherapy of cancer J Immunol 176 3 1582 1587 16424187 1:CAS:528:DC%2BD28XlsFynsw%3D%3D